Trial Profile
Predictors for therapeutic effect of Lusutrombopag in chronic liver disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2020
Price :
$35
*
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 27 Jul 2020 Status changed from recruiting to completed.
- 23 Jan 2017 New trial record